• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因治疗视网膜变性。

Gene Therapy for Retinal Degeneration.

机构信息

Washington University School of Medicine, 660 South Euclid Avenue, Box 8096, St. Louis, MO 63110, USA.

出版信息

Cell. 2018 Mar 22;173(1):5. doi: 10.1016/j.cell.2018.03.021.

DOI:10.1016/j.cell.2018.03.021
PMID:29570997
Abstract

Biallelic mutations in the RPE65 gene are associated with inherited retinal degenerations/dystrophies (IRD) and disrupt the visual cycle, leading to loss of vision. A new adenoviral vector-based gene therapy surgically delivered to retinal cells provides normal human RPE65 protein that can restore the visual cycle and some vision. To view this Bench to Bedside, open or download the PDF.

摘要

RPE65 基因的双等位基因突变与遗传性视网膜退行性疾病/营养不良(IRD)有关,并破坏视觉循环,导致视力丧失。一种新的腺相关病毒载体为基础的基因治疗方法通过手术递送至视网膜细胞,提供正常的人 RPE65 蛋白,可以恢复视觉循环和一些视力。要查看这个从实验室到临床的转化,请打开或下载 PDF。

相似文献

1
Gene Therapy for Retinal Degeneration.基因治疗视网膜变性。
Cell. 2018 Mar 22;173(1):5. doi: 10.1016/j.cell.2018.03.021.
2
Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.视网膜色素变性 RPE65 缺乏症基因治疗 5 年后的结果。
Hum Gene Ther. 2018 Dec;29(12):1428-1437. doi: 10.1089/hum.2018.014. Epub 2018 Jul 24.
3
Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.AAV4 基因治疗治疗 RPE65 型莱伯先天性黑矇患者的安全性和长期疗效。
Mol Ther. 2018 Jan 3;26(1):256-268. doi: 10.1016/j.ymthe.2017.09.014. Epub 2017 Sep 19.
4
The Status of RPE65 Gene Therapy Trials: Safety and Efficacy.RPE65基因治疗试验的现状:安全性与有效性。
Cold Spring Harb Perspect Med. 2015 Jan 29;5(9):a017285. doi: 10.1101/cshperspect.a017285.
5
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.尽管人类视网膜基因治疗先天性黑蒙 10 型的视力得到了持久改善,但仍显示出进行性视网膜变性。
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):E517-25. doi: 10.1073/pnas.1218933110. Epub 2013 Jan 22.
6
Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.基因治疗 RPE65 缺陷性莱伯先天性黑矇和严重早发性儿童期发病的视网膜营养不良的 2 年结果。
Ophthalmology. 2016 Jul;123(7):1606-20. doi: 10.1016/j.ophtha.2016.03.003. Epub 2016 Apr 19.
7
Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.作为再生医学的眼部基因治疗?来自RPE65基因治疗莱伯先天性黑蒙的经验教训。
Int J Biochem Cell Biol. 2014 Nov;56:153-7. doi: 10.1016/j.biocel.2014.09.022. Epub 2014 Oct 5.
8
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.针对因RPE65缺陷导致的莱伯先天性黑蒙症,开发一种优化的AAV2/5基因治疗载体。
Gene Ther. 2016 Dec;23(12):857-862. doi: 10.1038/gt.2016.66. Epub 2016 Sep 22.
9
Gene therapy for RPE65-related retinal disease.针对RPE65相关视网膜疾病的基因治疗。
Ophthalmic Genet. 2018 Dec;39(6):671-677. doi: 10.1080/13816810.2018.1533027. Epub 2018 Oct 18.
10
Current Management of Patients with RPE65 Mutation-Associated Inherited Retinal Degenerations in Europe: Results of a Multinational Survey by the European Vision Institute Clinical Research Network.当前欧洲 RPE65 突变相关遗传性视网膜退行性疾病患者的管理:欧洲视觉研究所临床研究网络多国调查的结果。
Ophthalmic Res. 2021;64(5):740-753. doi: 10.1159/000515688. Epub 2021 Mar 8.

引用本文的文献

1
AAV for Gene Therapy in Ocular Diseases: Progress and Prospects.用于眼部疾病基因治疗的腺相关病毒:进展与前景
Research (Wash D C). 2023 Dec 22;6:0291. doi: 10.34133/research.0291. eCollection 2023.
2
The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.rAAV2-RB1 介导的基因治疗在视网膜母细胞瘤中的应用。
Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):31. doi: 10.1167/iovs.64.15.31.
3
Comparison of retinal degeneration treatment with four types of different mesenchymal stem cells, human induced pluripotent stem cells and RPE cells in a rat retinal degeneration model.
在大鼠视网膜变性模型中比较四种不同间充质干细胞、人诱导多能干细胞和 RPE 细胞治疗视网膜变性的效果。
J Transl Med. 2023 Dec 14;21(1):910. doi: 10.1186/s12967-023-04785-1.
4
Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases.诱导多能干细胞和类器官在遗传性视网膜疾病中的应用。
Stem Cell Res Ther. 2023 Nov 27;14(1):340. doi: 10.1186/s13287-023-03564-5.
5
A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice.遗传性视网膜疾病的多学科诊疗方法:从诊断到初步治疗的叙述性综述,附有临床实践的投入。
Orphanet J Rare Dis. 2023 Jul 31;18(1):223. doi: 10.1186/s13023-023-02798-z.
6
Prime editing-based gene correction alleviates the hyperexcitable phenotype and seizures of a genetic epilepsy mouse model.基于碱基编辑的基因校正减轻了遗传性癫痫小鼠模型的过度兴奋表型和癫痫发作。
Acta Pharmacol Sin. 2023 Nov;44(11):2342-2345. doi: 10.1038/s41401-023-01115-5. Epub 2023 Jul 4.
7
Twenty-five years of clinical applications using adaptive optics ophthalmoscopy [Invited].使用自适应光学检眼镜的25年临床应用[特邀报告]
Biomed Opt Express. 2022 Dec 20;14(1):387-428. doi: 10.1364/BOE.472274. eCollection 2023 Jan 1.
8
Bioengineering Human Pluripotent Stem Cell-Derived Retinal Organoids and Optic Vesicle-Containing Brain Organoids for Ocular Diseases.生物工程人多能干细胞衍生的视网膜类器官和含视囊的脑类器官用于眼部疾病。
Cells. 2022 Oct 30;11(21):3429. doi: 10.3390/cells11213429.
9
Sight restoration reverses blindness-induced cross-modal functional connectivity changes between the visual and somatosensory cortex at rest.视力恢复可逆转静息状态下失明引起的视觉皮层与体感皮层之间跨模态功能连接的变化。
Front Neurosci. 2022 Sep 23;16:902866. doi: 10.3389/fnins.2022.902866. eCollection 2022.
10
miR-181a/b downregulation: a mutation-independent therapeutic approach for inherited retinal diseases.miR-181a/b 下调:一种与突变无关的遗传性视网膜疾病治疗方法。
EMBO Mol Med. 2022 Nov 8;14(11):e15941. doi: 10.15252/emmm.202215941. Epub 2022 Oct 4.